Lesion Sequence and Catheter Spatial Stability Affect Lesion Quality Markers in Atrial Fibrillation Ablation.


Journal

JACC. Clinical electrophysiology
ISSN: 2405-5018
Titre abrégé: JACC Clin Electrophysiol
Pays: United States
ID NLM: 101656995

Informations de publication

Date de publication:
03 2021
Historique:
received: 02 04 2020
revised: 03 09 2020
accepted: 23 09 2020
pubmed: 1 2 2021
medline: 19 8 2021
entrez: 31 1 2021
Statut: ppublish

Résumé

This study sought to analyze high-frequency catheter excursion in relation to lesion quality markers in 20 consecutive patients undergoing first-time radiofrequency (RF) ablation for paroxysmal atrial fibrillation (AF). Ablation therapy for AF requires the delivery of durable lesions. The extent to which lesion sequence, catheter spatial stability, and anatomic location influence lesion formation during RF ablation of AF is not well understood. Three-dimensional spatial excursion of the ablation catheter sampled at 60 Hz during pre-specified pairs of RF lesions was extracted from the CARTO3 System (Biosense Webster Inc., Irvine, California) and analyzed by using custom-developed MATLAB software (MathWorks, Natick, Massachusetts) to define precise catheter spatial stability during RF ablation. Ablation parameters including bipolar electrogram amplitude reduction, impedance decline and transmurality-associated unipolar electrogram (TUE) as evidence of lesion transmurality during lesion placement were recorded and analyzed. We collected 437,760 position data points during lesion placement. Ablation catheter spatial stability and lesion formation parameters varied considerably by anatomic location. Lesions placed immediately had similar bipolar electrogram amplitude reduction, smaller impedance decline, but higher likelihood of achieving TUE compared to delayed lesions. Greater catheter spatial stability correlated with lesser impedance decline. Lesion sequence, ablation catheter spatial stability, and anatomic location are important modifiers of RF lesion formation. Lesions placed immediately are more likely to exhibit TUE. Greater ablation catheter stability is associated with lesser impedance decline but greater likelihood of TUE.

Sections du résumé

OBJECTIVES
This study sought to analyze high-frequency catheter excursion in relation to lesion quality markers in 20 consecutive patients undergoing first-time radiofrequency (RF) ablation for paroxysmal atrial fibrillation (AF).
BACKGROUND
Ablation therapy for AF requires the delivery of durable lesions. The extent to which lesion sequence, catheter spatial stability, and anatomic location influence lesion formation during RF ablation of AF is not well understood.
METHODS
Three-dimensional spatial excursion of the ablation catheter sampled at 60 Hz during pre-specified pairs of RF lesions was extracted from the CARTO3 System (Biosense Webster Inc., Irvine, California) and analyzed by using custom-developed MATLAB software (MathWorks, Natick, Massachusetts) to define precise catheter spatial stability during RF ablation. Ablation parameters including bipolar electrogram amplitude reduction, impedance decline and transmurality-associated unipolar electrogram (TUE) as evidence of lesion transmurality during lesion placement were recorded and analyzed.
RESULTS
We collected 437,760 position data points during lesion placement. Ablation catheter spatial stability and lesion formation parameters varied considerably by anatomic location. Lesions placed immediately had similar bipolar electrogram amplitude reduction, smaller impedance decline, but higher likelihood of achieving TUE compared to delayed lesions. Greater catheter spatial stability correlated with lesser impedance decline.
CONCLUSIONS
Lesion sequence, ablation catheter spatial stability, and anatomic location are important modifiers of RF lesion formation. Lesions placed immediately are more likely to exhibit TUE. Greater ablation catheter stability is associated with lesser impedance decline but greater likelihood of TUE.

Identifiants

pubmed: 33516716
pii: S2405-500X(20)30976-2
doi: 10.1016/j.jacep.2020.09.027
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

367-377

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Funding Support and Author Disclosures Dr. Aizer has served as a consultant for Biosense Webster, Inc. Dr. Chinitz has received speaking fees/honoraria and Fellowship/Research funding from Biosense Webster, Inc. Dr. Jankelson owns intellectual property rights related to mapping and ablation. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Auteurs

Lior Jankelson (L)

Leon H. Charney Division of Cardiology, New York University Langone Medical Center, New York University School of Medicine, New York, New York, USA. Electronic address: lior.jankelson@nyumc.org.

Matthew Dai (M)

Leon H. Charney Division of Cardiology, New York University Langone Medical Center, New York University School of Medicine, New York, New York, USA.

Anthony Aizer (A)

Leon H. Charney Division of Cardiology, New York University Langone Medical Center, New York University School of Medicine, New York, New York, USA.

Scott Bernstein (S)

Leon H. Charney Division of Cardiology, New York University Langone Medical Center, New York University School of Medicine, New York, New York, USA.

David S Park (DS)

Leon H. Charney Division of Cardiology, New York University Langone Medical Center, New York University School of Medicine, New York, New York, USA.

Douglas Holmes (D)

Leon H. Charney Division of Cardiology, New York University Langone Medical Center, New York University School of Medicine, New York, New York, USA.

Larry A Chinitz (LA)

Leon H. Charney Division of Cardiology, New York University Langone Medical Center, New York University School of Medicine, New York, New York, USA.

Chirag Barbhaiya (C)

Leon H. Charney Division of Cardiology, New York University Langone Medical Center, New York University School of Medicine, New York, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH